KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Capital Expenditures (2016 - 2026)

Staar Surgical (STAA) has disclosed Capital Expenditures for 17 consecutive years, with $1.7 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures fell 70.71% year-over-year to $1.7 million, compared with a TTM value of $5.8 million through Jan 2026, down 75.12%, and an annual FY2026 reading of $5.8 million, down 75.12% over the prior year.
  • Capital Expenditures was $1.7 million for Q1 2026 at Staar Surgical, up from $883000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $9.2 million in Q3 2023 and bottomed at $883000.0 in Q3 2025.
  • Average Capital Expenditures over 5 years is $4.1 million, with a median of $3.6 million recorded in 2022.
  • The sharpest move saw Capital Expenditures surged 106.9% in 2024, then crashed 85.83% in 2025.
  • Year by year, Capital Expenditures stood at $4.0 million in 2022, then dropped by 23.28% to $3.1 million in 2023, then soared by 85.4% to $5.7 million in 2024, then plummeted by 84.58% to $883000.0 in 2025, then surged by 89.92% to $1.7 million in 2026.
  • Business Quant data shows Capital Expenditures for STAA at $1.7 million in Q1 2026, $883000.0 in Q3 2025, and $1.8 million in Q2 2025.